Details of the Drug Reposition

General Information of This Drug (ID: DMTEQEQ)

Drug Name
Galinpepimut-S   DMTEQEQ

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Acute myeloid leukaemia DIS0BM1I 2A60 Phase 3 [1]
------------------------------------------------------------------------------------
5 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Chronic myeloid leukaemia DISUMGPU 2A20 Phase 2 [2]
Multiple myeloma DISEWP9B 2A83 Phase 2 [3]
Malignant pleural mesothelioma DIST2R60 2C26.0 Phase 2 [3]
Mesothelioma DISKWK9M 2C51.2 Phase 2 [2]
Ovarian cancer DISZJHAP 2C73 Phase 2 [2]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04229979) GPS Compared With BAT in AML CR2/CR2p. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)